Alembic Pharma Q2 net surges 81% to ₹335 crore
Alembic Pharma reports 81% Q2 profit jump to ₹335 cr on 36% revenue rise, expands DifGen collaboration to boost U.S. growth.
BTC+0.31%
ETH+1.66%
SOL+0.87%
USDC-0.02%
XRP-0.01%
HYPE-4.93%
SUI-0.86%
DOGE-0.03%BTC+0.31%ETH+1.66%SOL+0.87%USDC-0.02%XRP-0.01%HYPE-4.93%SUI-0.86%DOGE-0.03%BTC+0.31%ETH+1.66%SOL+0.87%USDC-0.02%XRP-0.01%HYPE-4.93%SUI-0.86%DOGE-0.03%BTC+0.31%ETH+1.66%SOL+0.87%USDC-0.02%XRP-0.01%HYPE-4.93%SUI-0.86%DOGE-0.03%
